A better understanding of these issues and those that may emerge from novel clinical practices, treatments, and innovations, are necessary to provide adequate education for pathologists involved in the testing and diagnosis of RET-altered lung and thyroid cancers. The gene discussed is RET; the disease is thyroid gland carcinoma.